RAPP Australia Pty Ltd has been in operation for the last 30 years and is the parent company to the NEANN and firelogistics divisions.

TEST FOR PROFESSIONALS

RAPID TESTS FOR TRAINED PERSONNEL

We offer you the BfArM (AT321/21) and PEI listed, reimbursable Coretests®-COVID-19 Ag rapid test, the use of which is already well established. In medicine, so-called point-of-care testing (POCT) refers to diagnostic examinations that do not take place in a central laboratory, but on site (in pharmacies, test centers, hospitals, care facilities or doctor’s offices) by trained personnel.

Checklist

What’s special about our
COVID-19 Coretests® for professionals?

  • 3-in-1-Application by anterior nasal swab, nasopharyngeal swab and throat swab
  • Developed and manufactured according to EU standard 98/79 EC for in vitro diagnostics, CE marked
  • QR code with sequential number for unmistakable documentation
  • Clinical sensitivity: 98.1 %
  • Clinical specificity: 99.6 %
  • Detection limit of 22.5 TCID50/ml
  • BfArM listed under AT321/21, AT267/20 (Link)
  • RAT listed (2019) (Link)
  • PEI evaluated (Link)
  • For use by medical professionals only
  • Free from health-hazardous substances
  • Detection of viral mutations including omicron

AT A GLANCE

COVID-19 Coretests® for professionals

Icon

3 - 15 minutes

test time

The test result is available within 3 – 15 minutes.

Icon

2ºC–30ºC

storage

Easy handling and shelf life due to extended temperature range.

Icon

3-in-1-application

Sample type

Smear in the anterior nasal cavity, nasopharyngeal and pharyngeal.

TEST PROCEDURE

CORETESTS®-COVID-19 AG rapid tests for professionals

Contact us

RAPP Australia Pty Ltd – HEAD OFFICE

160-162 McClelland Ave,
P.O. Box 120,
Lara, Victoria, 3212
Australia

Phone:  1300 727 728
E-mail: sales@rappaustralia.com.au

Australian distributor of: